Pathophysiology of neuronal injury in bacterial meningitis: Concepts and implications

Neurologia

Volumn 18, Issue 2, 2003, Pages 47-53

  Nau, Roland ^a,b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL PROTEIN SYNTHESIS INHIBITOR; CASPASE; GLUTAMIC ACID; NEUTRALIZING ANTIBODY; PROTEIN SYNTHESIS INHIBITOR; REACTIVE OXYGEN METABOLITE; RECOMBINANT PERMEABILITY INCREASING PROTEIN; RECOMBINANT PROTEIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; APOPTOSIS; BACTERIAL MENINGITIS; BRAIN ATROPHY; BRAIN HYPOXIA; BRAIN ISCHEMIA; CLINICAL FEATURE; DISEASE MODEL; EARLY DIAGNOSIS; EDITORIAL; ENZYME ACTIVATION; ENZYME ACTIVITY; HAEMOPHILUS INFLUENZAE; HIPPOCAMPUS; HOST RESISTANCE; HUMAN; INFECTION RESISTANCE; INFLAMMATION; LEUKOCYTE MIGRATION; LISTERIA MONOCYTOGENES; MYCOBACTERIUM TUBERCULOSIS; NEISSERIA MENINGITIDIS; NERVE CELL LESION; NONHUMAN; PATHOPHYSIOLOGY; STREPTOCOCCUS PNEUMONIAE; SYMPTOM; ANIMAL; IMMUNOLOGY; ISCHEMIA; LEUKOCYTE; METABOLISM; MICROBIOLOGY; NERVE CELL;

ANIMALS; ANTI-BACTERIAL AGENTS; CASPASES; GLUTAMIC ACID; HUMANS; ISCHEMIA; LEUKOCYTES; MENINGITIS, BACTERIAL; NEURONS; REACTIVE OXYGEN SPECIES;

EID: 0037344506     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (57)

1. WHO Fact Sheet (http://www.who.int/inf-fs/en/fact105.html).
2. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS, et al. Acute bacterial meningitis in adults. A review of 493 episodes. New Engl J Med 1993;328:21-8.
3. Peltola H. Worldwide Haemophilus influenzae type B disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev 2000; 13:302-17.
4. Peltola H. Prophylaxis of bacterial meningitis. Infect Dis Clin North Am 1999;13:685-710.
5. Farber JM, Peterkin PI. Listeria monocytogenes, a food-borne pathogen. Microbiol Rev 1991;55:471-511.
6. Odio CM, Faingezicht I, Paris M, Nassar M, Baltodano A, Rogers J, et al. The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. New Engl J Med 1991;324:1525-31.
7. Cabellos C, Martinez-Lacasa J, Martos A, Tubau F, Fernandez A, Viladrich PF, et al. Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrob Agents Chemother 1995;39: 2158-60.
8. Zysk G, Brück W, Gerber J, Brück Y, Prange HW, Nau R. Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis. J Neuropathol Exp Neurol 1996;55:722-728.
9. Kim KS. Escherichia coli invasion of brain microvascular endothelial cells as a pathogenetic basis of meningitis. Subeell Biochem 2000;33:47-59.
10. Zysk G, Brück W, Huitinga I, Fischer FR, Flachsbarth F, van Rooijen N, et al. Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitis. J Neuroimmunol 1997;73:77-80.
11. Trostdorf F, Brück W, Schmitz-Salue M, Stuertz K, Hopkins SJ, van Rooijen N, et al. Reduction of meningeal macrophages does not decrease migration of granulocytes into the CSF and brain parenchyma in experimental pneumococcal meningitis. J Neuroimmunol 1999;99:205-10.
12. Täuber MG, Moser B. Cytokines and chemokines in meningeal inflammation: biology and clinical implications. Clin Infect Dis 1999;28:1-11.
13. Polfliet MM, Zwijnenburg PJ, van Furth AM, van der Poll T, Dopp EA, Renardel de Lavalette C, et al. Meningeal macrophages of the central nervous system play a protective role during bacterial meningitis. J Immunol 2001;167:4644-50.
14. Braun JS, Novak R, Herzog KH, Bodner SM, Cleveland JL, Tuomanen El. Neuroprotection by a caspase inhibitor in acute bacterial meningitis. Nat Med 1999;5:298-302.
15. Nau R, Soto A, Brück W. Apoptosis of neurons in the dentate gyrus in humans dying from bacterial meningitis. J Neuropathol Exp Neurol 1999;58:265-74.
16. Leib SL, Kim YS, Chow LL, Sheldon RA, Täuber MG. Reactive oxygen intermediates contribute to necrotic and apoptotic neuronal injury in an infant rat model of bacterial meningitis due to group B streptococci. J Clin Invest 1996;8:2632-9.
17. Schmidt H, Tlustochowska A, Stuertz K, Djukic M, Gerber J, Schütz E, et al. Organotypic hippocampal cultures. A model of brain tissue damage in Streptococcus pneumoniae meningitis. J Neuroimmunol 2001;113:30-9.
18. Gerber J, Brück W, Stadelmann C, Bunkowski S, Lassmann H, Nau R. Expression of death-related proteins in dentate granule cells in human bacterial meningitis. Brain Pathol 2001;11:422-31.
19. Gerber J, Raivich G, Wellmer A, Noeske C, Kunst T, Werner A, et al. A mouse model of Streptococcus pneumoniae meningitis mimicking several features of human disease. Acta Neuropathol 2001;101:499-508.
20. Free SL, Li LM, Fish DR, Shorvon SD, Stevens JM. Bilateral hippocampal volume loss in patients with a history of encephalitis or meningitis. Epilepsia 1996;37:400-5.
21. Wellmer A, Noeske C, Gerber J, Munzel U, Nau R. Spatial memory and learning deficits after experimental pneumococcal meningitis in mice. Neurosci Lett 2000;296:137-40.
22. Loeffler JM, Ringer R, Hablützel M, Täuber MG, Leib SL. The free radical scavenger a-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J Infect Dis 2001;183:247-52.
23. Zysk G, Schneider-Wald BK, Hwang JH, Bejo L, Kim KS, Mitchell TJ, et al. Pneumolysin is the main inducer of cytotoxicity to brain microvascular endothelia cells caused by Streptococcus pneumoniae. Infect Immun 2001;69:845-52.
24. Hirst RA, Sikand KS, Rutman A, Mitchell TJ, Andrew PW, O'Callaghan C. Relative roles of pneumolysin and hydrogen peroxide from Streptococcus pneumoniae in inhibition of ependymal ciliary beat frequency. Infect Immun 2000;68:1557-62.
25. Michel U, Zobotke R, Mäder M, Nau R. Regulation of matrix metal loproteinase expression in endothelial cells by heat-inactivated Streptococcus pneumoniae. Infect Immun 2001;69: 1914-6.
26. Kim YS, Täuber MG. Neurotoxicity of glia activated by gram-positive bacterial products depends on nitric oxide production. Infect Immun 1996;64:3148-53.
27. Mering MV, Wellmer A, Michel U, Bunkowski S, Tlustochowska A, Brück W, et al. Transcriptional regulation of caspases in experimental pneumococcal meningitis. Brain Pathol 2001;11: 282-95.
28. Akira S, Takeda K, Kaisho T. Toll-like receptors: ctitical proteins linking innate and acquired immunity. Nature Immunol 2001;2:675-80.
29. 2 mediate brain cell apoptosis during meningitis. J Clin Invest 2002; 109:19-27.
30. Stringaris A K, Bergmann F, Geisenhainer J, Bähr M, Nau R. Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen activated protein kinase. Neurology 2002;58(Suppl 3): 262-3.
31. Vereker E, Campbell V, Roche E, McEntee E, Lynch MA. Lipopolysaccharide inhibits long term potentiation in the rat dentate gyrus by activating caspase-1. J Biol Chem 2000;275: 26252-8.
32. Schneider O, Michel U, Zysk G, Dubuis O, Nau R. Clinical outcome in pneumococcal meningitis correlates with CSF lipoteichoic acid concentrations. Neurology 1999;53:1584-7.
33. Azeh I, Mäder M, Smirnov A, Beuche W, Nau R, Weber F. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion. Neurosci Lett 1998;256:127-30.
34. Leib SL, Leppert D, Clements J, Täuber MG. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun 2000;68:615-20.
35. Braun JS, Novak R, Gao G, Murray PJ, Shenep JL. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages. Infect Immun 1999;67: 3750-6.
36. Ring A, Braun JS, Nizet V, Stremmel W, Shenep JL. Group B streptococcal beta-hemolysin induces nitric oxide production in murine macrophages. J Infect Dis 2000;182:150-7.
37. Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, et al. Inhibition of matrix metalloproteinases and tumor necrosis factor a converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 2001;124:1734-42.
38. Bogdan I, Leib SL, Bergeron M, Chow L, Täuber MG. Tumor necrosis factor-alpha contributes to apoptosis in hippocampal neurons during experimental group B streptococcal meningitis. J Infect Dis 1997;176:693-7.
39. Eves EM, Skoczylas C, Yoshida K, Alnemri ES, Rosner MR. FGF induces a switch in death receptor pathways in neuronal cells. J Neurosci 2001;21:4996-5006.
40. Wellmer A, Gerber J, Ragheb J, Zysk G, Kunst T, Smirnov A, et al. Effect of deficiency of tumor necrosis factor alpha or both of its receptors on Streptococcus pneumoniae central nervous system infection and peritonitis. Infect Immun 2001;69:6881-6.
41. Pfister HW, Borasio GD, Dirnagl U, Bauer M, Einhäupl K. Cerebrovascular complications of bacterial meningitis in adults. Neurology 1992;42:1497-504.
42. Pfister LA, Tureen JH, Shaw S, Christen S, Ferriero D, Täuber MG, et al. Endothelin inhibition improves cerebral blood flow and is neuroprotective in pneumococcal meningitis. Ann Neurol 2000;47:329-35.
43. Koedel U, Pfister HW. Oxidative stress in bacterial meningitis. Brain Pathol 1999;9:57-7.
44. Guerra-Romero L, Tureen JH, Fournier MA, Makrides V, Täuber MG. Amino acids in cerebrospinal and brain interstitial fluid during experimental pneumococcal meningitis. Pediatr Res 1993;33:510-3.
45. Spranger M, Krempien S, Schwab S, Maiwald M, Bruno K, Hacke W. Excess glutamate levels in the cerebrospinal fluid predict clinical outcome of bacterial meningitis. Arch Neurol 1996; 53:992-6.
46. Leib SL, Kim YS, Ferriero DM, Täuber MG. Neuroprotective effect of excitatory amino acid antagonist kynurenic acid in experimental bacterial meningitis. J Infect Dis 1996;173:166-71.
47. Stringaris AK, Brück W, Tumani H, Schmidt H, Nau R. Increased glutamine synthetase immunoreactivity in experimental pneumococcal meningitis. Acta Neuropathol 1997;93:215-8.
48. Tumani H, Smirnov A, Barchfeld S, Olgemöller U, Maier K, Lange P, et al. Inhibition of glutamine synthetase in rabbit pneumococcal meningitis is associated with neuronal apoptosis in the dentate gyrus. Glia 2000;30:11-8.
49. Liu B, Wang K, Gao H-M, Mandavilli B, Wang J-Y, Hong J-S. Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem 2001;77:182-9.
50. Dirnagl U, ladecola C, Moskowitz MA. Pathobiology of ischemic stroke: an integrated view. Trends Neurosci 1999;22:391-7.
51. Nau R, Wellmer A, Soto A, Koch K, Schneider O, Schmidt H, et al. Rifampicin reduces early mortality in experimental Strcptococ Streptococcus pneumoniae meningitis. J Infect Dis 1999;179:1557-60.
52. Böttcher T, Gerber J, Wellmer A, Smirnov AV, Fakhrjanali F, Mix E, et al. Rifampin reduces production of reactive oxygen species of CSF phagocytes and hippocampal neuronal apoptosis in experimental Streptococcus pneumoniae meningitis. J Infect Dis 2000;181:2095-8.
53. Azeh I, Gerber J, Wellmer A, Wellhausen M, König B, Eiffert H, et al. The protein synthesis inhibiting clindamycin improves outcome in a mouse model of Staphylococcus aureus sepsis compared to the cell wall active ceftriaxone. Crit Care Med 2002;30:1560-4.
54. Kartalija M, Kim Y, White ML, Nau R, Tureen JH, Täuber MG. Effect of a recombinant N-terminal fragment of bactericidal/permeability-increasing protein (rBP123) on cerebrospinal fluid inflammation induced by endotoxin. J Infect Dis 1995;171:948-53.
55. Tuomanen EI, Saukkonen K, Sande S, Cioffe C, Wright SD. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med 1989;170:959-68.
56. Auer M, Pfister LA, Leppert D, Täuber MG, Leib SL. Effects of clinically used antioxidants in experimental pneumococcal meningitis. J Infect Dis 2000;182:347-50.
57. Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW, Pharmacological interference with NF-kappaB activity attenuates central nervous system complications in experimental pneumococcal meningitis. J Infect Dis 2000;182:1437-45.